These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11371397)

  • 21. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
    Keller BM; Aebischer CC; Kraemer R; Schöni MH
    J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.
    Li Z; Lai HJ; Kosorok MR; Laxova A; Rock MJ; Splaingard ML; Farrell PM
    Pediatr Pulmonol; 2004 Oct; 38(4):277-84. PubMed ID: 15334503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Socioeconomic Status, Smoke Exposure, and Health Outcomes in Young Children With Cystic Fibrosis.
    Ong T; Schechter M; Yang J; Peng L; Emerson J; Gibson RL; Morgan W; Rosenfeld M;
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28093464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparities in Mortality of Hispanic Patients with Cystic Fibrosis in the United States. A National and Regional Cohort Study.
    Rho J; Ahn C; Gao A; Sawicki GS; Keller A; Jain R
    Am J Respir Crit Care Med; 2018 Oct; 198(8):1055-1063. PubMed ID: 29742360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States.
    Sawicki GS; Ostrenga J; Petren K; Fink AK; D'Agostino E; Strassle C; Schechter MS; Rosenfeld M
    Ann Am Thorac Soc; 2018 Feb; 15(2):234-240. PubMed ID: 29220199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Medicaid to uninsured: drop-out among children in public insurance programs.
    Sommers BD
    Health Serv Res; 2005 Feb; 40(1):59-78. PubMed ID: 15663702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparity in drug-eluting stent utilization by insurance type.
    Kao J; Vicuna R; House JA; Rumsfeld JS; Ting HH; Spertus JA
    Am Heart J; 2008 Dec; 156(6):1133-40. PubMed ID: 19033009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis.
    Konstan MW; VanDevanter DR; Sawicki GS; Pasta DJ; Foreman AJ; Neiman EA; Morgan WJ
    Ann Am Thorac Soc; 2018 Apr; 15(4):485-493. PubMed ID: 29313709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of published evidence on outcomes with early diagnosis from large US observational studies.
    Rosenfeld M
    J Pediatr; 2005 Sep; 147(3 Suppl):S11-4. PubMed ID: 16202774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
    de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
    Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insurance status and access to health services among poor persons.
    Freeman HE; Corey CR
    Health Serv Res; 1993 Dec; 28(5):531-41. PubMed ID: 8270419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health insurance and use of recommended routine care in adults with cystic fibrosis.
    Li SS; Hayes D; Tobias JD; Morgan WJ; Tumin D
    Clin Respir J; 2018 May; 12(5):1981-1988. PubMed ID: 29356436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insurance status is related to diffuse large B-cell lymphoma survival.
    Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E
    Cancer; 2014 Apr; 120(8):1220-7. PubMed ID: 24474436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Median household income and mortality rate in cystic fibrosis.
    O'Connor GT; Quinton HB; Kneeland T; Kahn R; Lever T; Maddock J; Robichaud P; Detzer M; Swartz DR
    Pediatrics; 2003 Apr; 111(4 Pt 1):e333-9. PubMed ID: 12671148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of financial barriers to pediatric cochlear implantation: impact of socioeconomic status on access and outcomes.
    Chang DT; Ko AB; Murray GS; Arnold JE; Megerian CA
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):648-57. PubMed ID: 20644058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis.
    Curtis JR; Burke W; Kassner AW; Aitken ML
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1921-4. PubMed ID: 9196096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does payer status impact clinical outcomes after cardiac surgery? A propensity analysis.
    Polanco A; Breglio AM; Itagaki S; Goldstone AB; Chikwe J
    Heart Surg Forum; 2012 Oct; 15(5):E262-7. PubMed ID: 23092662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value for the money spent? Exploring the relationship between expenditures, insurance adequacy, and access to care for publicly insured children.
    Colby MS; Lipson DJ; Turchin SR
    Matern Child Health J; 2012 Apr; 16 Suppl 1():S51-60. PubMed ID: 22476794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparities in pulmonary fibrosis care in the United States: an analysis from the Nationwide Inpatient Sample.
    Gaffney AW; Woolhander S; Himmelstein D; McCormick D
    BMC Health Serv Res; 2018 Aug; 18(1):618. PubMed ID: 30089521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.